Hepatic ChREBP activation limits NAFLD development in a mouse model for Glycogen Storage Disease type Ia/ Normalization of ChREBP activity in hepatic GSD Ia accelerates liver disease progression and sensitizes towards hepatocellular tumour formation.

Accession: GSE143357
Source / host: GEO — NCBI GEO FTP
Disease relevance: MASLD / NAFLD / NASH (category: Transcriptomic, subtype: bulk RNA-seq)
Modality / assay: bulk-RNAseq
Platform: Expression profiling by high throughput sequencing, 17021
Organism: mouse
Samples: 33
Size (indexed): (None bytes)
Downloaded bytes: 2.4 MB (2505663 bytes)
Access / raw: public /

Download

Files

FileSizeSHA256
GSE143357_counts.txt.gz700.7 KB5e71ddfd5f93faf8…
GSE143357_voom.txt.gz1.7 MB2ea58436d0ee5ad3…

Crawled by masld-atlas-crawler v1.0 at 2026-08-06T07:15:27Z.

About this dataset

This Expression profiling by high throughput sequencing, 17021 dataset provides single-cell gene expression from mouse liver samples, with disease state recorded as MASLD/NAFLD/NASH. It profiles about 33 cells or nuclei.

Analyze it in Drylab

Open this dataset in Drylab and ask a question in plain language. The AI agent loads the files, runs the analysis in a ready sandbox and explains each result. A typical first pass:

  1. Load the filtered feature-barcode matrix (HDF5) and run quality control on counts, genes and mitochondrial reads per cell.
  2. Normalize, select variable genes, then cluster the cells and draw a UMAP.
  3. Annotate clusters with marker genes and compare the cell-type mix between conditions.
  4. Run differential expression between cell types or samples to characterize masld/nafld/nash biology.